Risch, Zug, Switzerland
Strategic and results-driven global leader with over 20 years of experience, confident to shape and drive operational excellence and strategic growth within complex multinational organizations. My expertise spans business strategy, financial planning, program leadership, and enterprise-wide transformation, consistently leveraging data-driven approaches to achieve sustainable growth and market leadership. I am passionate about integrating cutting-edge capabilities like Data, Digital/AI, and Business Model Design to foster innovation, accelerate decision-making, and optimize operational efficiency within highly regulated environments. As a proven and empathetic leader, I excel at building and leading high-performing, cross-functional, and cross-cultural teams (including teams of 30+ professionals) to deliver exceptional business outcomes, enhance profitability, and ensure strict compliance and governance adherence. Key Impact Areas: - Strategic & Operational Leadership: Successfully led global commercial transformation initiatives, aligning divisional strategy with corporate objectives to enhance operational effectiveness and drive sustainable growth. Improved operational efficiency by 23% through agile methodologies and standardization, reducing planning efforts by over 30%. - Financial Acumen & Business Control: Drove financial planning, budgeting (managed annual budgets exceeding 5 mCHF), strengthening financial risk management and ensuring cost-efficient deal structures. Delivered a 10% increase in operational profit for a major affiliate within two years. - Transformation & Digital Acceleration: Spearheaded the transformation of US & Canada diagnostics affiliates, accelerating decision-making and operational efficiency through lean governance. Directed complex transformation projects achieving sustainable annual cost savings of 3-5 mCHF and one-off savings of 3 mCHF. - Compliance & Risk Management: Directed risk and business continuity management for critical manufacturing sites, ensuring compliance with global regulatory standards, including GMP and GCP. - Executive & Stakeholder Engagement: Proficient at influencing senior stakeholders and partnering with executives and regional leaders to execute data-driven commercial strategies, achieving market leadership with a 31.5% market share (10% above competitors).
Enabling business excellence and salesforce effectiveness within Roche Diabetes Care through global commercial transformation, strategic alignment, and operational optimization, consistently achieving market leadership and financial growth. Strategic Leadership: - Co-developed and executed commercial strategies: Leading to sustained financial success and a 31.5% BGM market share in a very mature market, surpassing competitors by 10%. - Oversaw annual strategy reviews: Enhancing profitability in a competitive market through meticulous monitoring and strategic follow-ups. Transformation Leadership: - Spearheaded transformation of US & Canada diagnostics affiliates: Accelerating decision-making and operational efficiency through lean governance. - Led global commercial transformation: Aligning divisional and corporate strategies for enhanced operational effectiveness. - Integrated two commercial regions into a cohesive global organization: Successfully onboarding General Managers from around the world. High-Performing Teams: - Built and led global teams: Focused on talent development and implementing customer-centric strategies driving significant business growth and customer satisfaction. - Collaborated with executives and regional leaders: To drive commercial strategies, achieving market leadership. Financial Planning and Accountability: - Led financial planning and budgeting: Closely aligned with business priorities. - Owned and improved Commercial OKRs: Driving transparency in business performance and necessary course corrections. Thought Leadership: - Co-developed strategic frameworks for Commercial Excellence: With strong stakeholder support. - Co-led global projects assessing local business models: To enhance commercial effectiveness. Communicate effectively and demonstrate strong interpersonal skills, demonstrating adaptability, resilience, and a commitment to ethical practices and corporate social responsibility.
As Head of the Commercial Project Management Office, I drove commercial success and strategic growth across diverse regions, including Asia, Africa, the Middle East, and LATAM through leadership, innovation, and global expertise in the evolving landscape of Diabetes Care. - Executed end-to-end commercial projects: Seamlessly managed projects from initial scoping to final delivery, ensuring efficiency and excellence across all initiatives. - Directed regional commercial strategies: Led commercial strategies in Asia, Africa, the Middle East, and LATAM, which resulted in sustained profitability and solidified market leadership. - Enhanced financial risk management: Revamped contract negotiations and compliance frameworks, significantly mitigating financial exposure and ensuring business continuity. - Restructured a major affiliate: Achieved a substantial operational profit increase of 10 percentage points within two years, aligning P&L with clear performance targets. - Led innovative initiatives and global challenges, winning a critical tender in Brazil, creating new business opportunities and addressing changing market needs.
Throughout my role as Innovation Project Leader, I have consistently demonstrated my ability to align financial planning with strategic goals, expand market opportunities, and foster collaboration to drive significant improvements in product development and market presence. Innovating and leading transformative projects in the R&D sector focused on driving growth, market expansion and R&D efficiency. - Directed Financial Planning & Budgeting: Managed the Skin Lightening Product Portfolio in Asia with an annual development budget of CHF 3 million, achieving a 15% reduction in overall project costs through strategic resource allocation. - Strategic Product Portfolio Expansion: Implemented strategies that led to a 20% increase in segment revenue and a 15% acceleration in go-to-market time. - Enhanced Product Development Cycle: Partnered with the R&D team to identify high-potential lead candidates, significantly reducing the product development cycle and improving the pipeline's quality and profitability. - Impactful Marketing Campaigns: Co-developed marketing campaigns for individual compounds and the overall skin lightening platform, contributing to a double-digit-% increase in customer engagement and product awareness.
I significantly enhanced peptide production capabilities and drove strategic product development initiatives, achieving remarkable innovation and collaboration. Additionally, I managed the comprehensive end-to-end manufacturing process, ensuring timely delivery and impeccable quality of products. My leadership extended to overseeing a team of lab technicians specialized in synthesis, in-process control, purification, and troubleshooting, driving process efficiency and performance. Oversaw the manufacturing of a diverse commercial portfolio comprising over 150 peptides, ensuring full cGMP compliance and regulatory standards were met consistently. - Spearheaded peptide production and product development: Fostered robust collaboration with external partners and internal stakeholders, generating new business revenues amounting to 2-3 mCHF annually. - Conducted and led customer and safety audits: Ensured compliance and maintained the highest operational standards, reinforcing a culture of excellence. - Oversaw cost center and budget: Managed a yearly budget of 2 mCHF for commercial peptide production, exercising prudent financial management and ensuring budget adherence. - Directed insourcing, upscaling, and technology transfer initiatives: Facilitated transition into DSM’s large-scale manufacturing site, yielding annual recurring savings exceeding 2.2 mCHF. - Secured high-value business contracts: Instrumental in business development for large Pharmaceutical & Diagnostics customers, securing a 3.5 mCHF contract for critical diagnostic test ingredients.
Optimized manufacturing processes and comprehensive training programs that enhance efficiency, compliance, and safety. By integrating advanced technical expertise with robust writing skills, I bridged scientific innovation with operational excellence, driving both organizational growth and continuous improvement. - Manufacturing Process Optimization: Spearheaded the optimization of manufacturing processes for novel peptides in Phase II clinical trials. This initiative not only increased production efficiency but also maintained rigorous adherence to cGMP standards. The result was a significant reduction in overall production costs and cycle times, effectively accelerating the timeline for clinical trial progression. - Cost and Time Efficiency: Implemented strategies that led to a noticeable decrease in production expenses and cycle durations, supporting faster clinical trials and timely delivery of high-quality outputs, essential for maintaining competitive advantage in the pharmaceutical API sector. - Training and Upskilling: Designed and implemented comprehensive training programs that upskilled over 50 personnel in areas such as cGMP, occupational safety, and hygiene practices. This effort not only improved compliance but also resulted in a 40% reduction in workplace incidents, thereby ensuring adherence to regulatory requirements and enhancing overall employee safety and productivity. - Regulatory Compliance Improvement: Developed and enforced protocols and training sessions that ensured stringent compliance with industry regulations, significantly reducing non-compliance incidents and fostering a culture of accountability and adherence to established guidelines within the organization. - Safety Enhancement: Facilitated a safer working environment through meticulous training and adherence to safety standards, evidenced by a marked reduction in workplace incidents, contributing to a more secure and productive workforce.